Key facts
| Price (PPV) | 3,395 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | temozolomide |
| Class | Antineoplastic agents |
| ATC code | L01AX03 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite de 5 |
| Hospital price | 3,083 MAD |
| Data collected on | 9/8/2026 |
Indications
Temozolomide est indiqué dans le traitement: des glioblastomes multiformes nouvellement diagnostiqués, en association avec la radiothérapie puis, comme traitement d'entretien des gliomes malins récidivants, comme les glioblastomes multiformes et les astrocytomes anaplasiques.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
One other product contains the same active substance as Temozolomide Zenith 250 mg (Temozolomide), at the same strength and in the same dosage form. The prices below are per pack: compare pack sizes before comparing prices.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Tegozol 250 mg | PROMOPHARM (HIKMA) | Flacon de 5 | 3,395 MAD | — |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Temozolomide Zenith 250 mg
Temozolomide Zenith 250 mg belongs to the antineoplastic agents therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Temozolomide Zenith 250 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Temozolomide Zenith 250 mg
Answers to common questions from Moroccan patients about this drug.